Lab testing continues to be an integral part of care delivery, but regulatory changes have negatively impacted reimbursement. With the stabilization in reimbursement resulting from the first round of the Protecting Access to Medicare Act, transaction activity has slowed, however this sector is still in need of disruption and labs are looking for ways to streamline costs and improve cash flow.